TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages

被引:54
作者
Takano, Tomomi [1 ]
Hohdatsu, Tsutomu [1 ]
Toda, Ayako [1 ]
Tanabe, Maki [1 ]
Koyama, Hiroyuki [1 ]
机构
[1] Kitasato Univ, Sch Vet Med & Anim Sci, Dept Vet Infect Dis, Towada, Aomori 034, Japan
关键词
FIP; ADE; TNF-alpha; fAPN;
D O I
10.1016/j.virol.2007.02.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The pathogenicity of feline infectious peritonitis virus (FIPV) is known to depend on macrophage tropism, and this macrophage infection is enhanced by mediation via anti-S antibody (antibody-dependent enhancement, ADE). In this study, we found that TNF-alpha production was increased with viral replication in macrophages inoculated with a mixture of FIPV and anti-S antibody, and demonstrated that this culture supernatant had feline PBMC apoptosis-inducing activity. We also demonstrated that the expression level of the FIPV virus receptor, feline aminopeptidase N (fAPN), was increased in macrophages of FIP cats. For upregulation of TNF-alpha and fAPN in macrophages, viral replication in macrophages is necessary, and their expressions were increased by ADE of FIPV infection. It was demonstrated that a heat-resistant fAPN-inducing factor was present in the culture supernatant of FIPV-infected macrophages, and this factor was TNF-alpha: fAPN expression was upregulated in recombinant feline TNF-alpha-treated macrophages, and FIPV infectivity was increased in these macrophages. These findings suggested that FIPV replication in macrophages increases TNF-alpha production in macrophages, and the produced TNF-alpha acts and upregulates fAPN expression, increasing FIPV sensitivity. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:64 / 72
页数:9
相关论文
共 34 条
[31]   Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets [J].
Weingartl, H ;
Czub, M ;
Czub, S ;
Neufeld, J ;
Marszal, P ;
Gren, J ;
Smith, G ;
Jones, S ;
Proulx, R ;
Deschambault, Y ;
Grudeski, E ;
Andonov, A ;
He, RT ;
Li, Y ;
Copps, J ;
Grolla, A ;
Dick, D ;
Berry, J ;
Ganske, S ;
Manning, L ;
Cao, JX .
JOURNAL OF VIROLOGY, 2004, 78 (22) :12672-12676
[32]   Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses [J].
Yang, ZY ;
Werner, HC ;
Kong, WP ;
Leung, K ;
Traggiai, E ;
Lanzavecchia, A ;
Nabel, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :797-801
[33]   HUMAN AMINOPEPTIDASE-N IS A RECEPTOR FOR HUMAN CORONAVIRUS-229E [J].
YEAGER, CL ;
ASHMUN, RA ;
WILLIAMS, RK ;
CARDELLICHIO, CB ;
SHAPIRO, LH ;
LOOK, AT ;
HOLMES, KV .
NATURE, 1992, 357 (6377) :420-422
[34]   Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: Involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha [J].
Yonezawa, A ;
Cavrois, M ;
Greene, WC .
JOURNAL OF VIROLOGY, 2005, 79 (02) :918-926